Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CivaDerm

K-Number: K191324 · 2019-09-20

Decision Date2019-09-20
Product CodeKXK
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

CivaDerm is a medical device manufactured by Civatech Oncology, Inc.. It received FDA 510(k) clearance on 2019-09-20 under approval number K191324. The device is classified under product code KXK. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CivaDerm?

CivaDerm is a medical device that received FDA 510(k) clearance on 2019-09-20. It is manufactured by Civatech Oncology, Inc.. The 510(k) number is K191324.

When was CivaDerm approved by the FDA?

CivaDerm received FDA 510(k) clearance on 2019-09-20, under approval number K191324.

What company makes CivaDerm?

CivaDerm is manufactured by Civatech Oncology, Inc..

What is the FDA product code for CivaDerm?

The FDA product code for CivaDerm is KXK.

Related Devices (Code: KXK)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.